Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 273

    1.

    The aminoquinoline surfen inhibits the action of semen-derived enhancer of viral infection (SEVI).

    Roan NR, Sowinski S, Muench J, Kirchhoff F, Greene WC.

    J Biol Chem. 2009 Nov 6. [Epub ahead of print]PMID: 19897482 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    The challenge of finding a cure for HIV infection.

    Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ.

    Science. 2009 Mar 6;323(5919):1304-7. Review.PMID: 19265012 [PubMed - indexed for MEDLINE]Related articles

    3.

    Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo.

    Michel N, Goffinet C, Ganter K, Allespach I, Kewalramani VN, Saifuddin M, Littman DR, Greene WC, Goldsmith MA, Keppler OT.

    Retrovirology. 2009 Jan 13;6:2.PMID: 19144136 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Unsung hero Robert C. Gallo.

    Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D.

    Science. 2009 Jan 9;323(5911):206-7. No abstract available. PMID: 19131607 [PubMed - indexed for MEDLINE]Related articles

    5.

    APOBEC3G: an intracellular centurion.

    Chiu YL, Greene WC.

    Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):689-703. Review.PMID: 19008196 [PubMed - indexed for MEDLINE]Related articles

    6.

    Guidelines for naming nonprimate APOBEC3 genes and proteins.

    LaRue RS, Andrésdóttir V, Blanchard Y, Conticello SG, Derse D, Emerman M, Greene WC, Jónsson SR, Landau NR, Löchelt M, Malik HS, Malim MH, Münk C, O'Brien SJ, Pathak VK, Strebel K, Wain-Hobson S, Yu XF, Yuhki N, Harris RS.

    J Virol. 2009 Jan;83(2):494-7. Epub 2008 Nov 5. No abstract available. PMID: 18987154 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection.

    Roan NR, Münch J, Arhel N, Mothes W, Neidleman J, Kobayashi A, Smith-McCune K, Kirchhoff F, Greene WC.

    J Virol. 2009 Jan;83(1):73-80. Epub 2008 Oct 22.PMID: 18945786 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Novel targets for HIV therapy.

    Greene WC, Debyser Z, Ikeda Y, Freed EO, Stephens E, Yonemoto W, Buckheit RW, Esté JA, Cihlar T.

    Antiviral Res. 2008 Dec;80(3):251-65. Epub 2008 Sep 30.PMID: 18789977 [PubMed - indexed for MEDLINE]Related articles

    9.

    Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.

    Santiago ML, Montano M, Benitez R, Messer RJ, Yonemoto W, Chesebro B, Hasenkrug KJ, Greene WC.

    Science. 2008 Sep 5;321(5894):1343-6.PMID: 18772436 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    HIV vaccine research: the way forward.

    Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, Martin M, Overbaugh J, Watkins DI, Mahmoud A, Greene WC.

    Science. 2008 Jul 25;321(5888):530-2.PMID: 18653883 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The achilles heel of the trojan horse model of HIV-1 trans-infection.

    Cavrois M, Neidleman J, Greene WC.

    PLoS Pathog. 2008 Jun 27;4(6):e1000051. Review.PMID: 18584030 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation.

    Kwon HS, Brent MM, Getachew R, Jayakumar P, Chen LF, Schnolzer M, McBurney MW, Marmorstein R, Greene WC, Ott M.

    Cell Host Microbe. 2008 Mar 13;3(3):158-67.PMID: 18329615 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.

    Chiu YL, Greene WC.

    Annu Rev Immunol. 2008;26:317-53. Review.PMID: 18304004 [PubMed - indexed for MEDLINE]Related articles

    14.

    A seminal finding for understanding HIV transmission.

    Roan NR, Greene WC.

    Cell. 2007 Dec 14;131(6):1044-6.PMID: 18083095 [PubMed - indexed for MEDLINE]Related articles

    15.

    A history of AIDS: looking back to see ahead.

    Greene WC.

    Eur J Immunol. 2007 Nov;37 Suppl 1:S94-102. Review. Erratum in: Eur J Immunol. 2008 Jan;38(1):309. PMID: 17972351 [PubMed - indexed for MEDLINE]Related articles

    16.

    Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.

    Goffinet C, Michel N, Allespach I, Tervo HM, Hermann V, Kräusslich HG, Greene WC, Keppler OT.

    Retrovirology. 2007 Jul 26;4:53.PMID: 17655755 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Regulation of HIV-1 latency by T-cell activation.

    Williams SA, Greene WC.

    Cytokine. 2007 Jul;39(1):63-74. Epub 2007 Jul 20. Review.PMID: 17643313 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo.

    Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, Sonza S, Crowe SM.

    J Immunol. 2007 May 15;178(10):6581-9.PMID: 17475889 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1.

    Williams SA, Kwon H, Chen LF, Greene WC.

    J Virol. 2007 Jun;81(11):6043-56. Epub 2007 Mar 21.PMID: 17376917 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    APOBEC3G and HIV-1: strike and counterstrike.

    Soros VB, Greene WC.

    Curr HIV/AIDS Rep. 2007 Feb;4(1):3-9.PMID: 17338854 [PubMed]Related articles

    21.

    Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.

    Soros VB, Yonemoto W, Greene WC.

    PLoS Pathog. 2007 Feb;3(2):e15.PMID: 17291161 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions.

    Cavrois M, Neidleman J, Kreisberg JF, Greene WC.

    PLoS Pathog. 2007 Jan;3(1):e4.PMID: 17238285 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells.

    Stopak KS, Chiu YL, Kropp J, Grant RM, Greene WC.

    J Biol Chem. 2007 Feb 9;282(6):3539-46. Epub 2006 Nov 16.PMID: 17110377 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    A plea for justice for jailed medical workers.

    Ahuja SK, Aiuti F, Berkhout B, Biberfeld P, Burton DR, Colizzi V, Deeks SG, Desrosiers RC, Dierich MP, Doms RW, Emerman M, Gallo RC, Girard M, Greene WC, Hoxie JA, Hunter E, Klein G, Korber B, Kuritzkes DR, Lederman MM, Malim MH, Marx PA, McCune JM, McMichael A, Miller C, Miller V, Montagnier L, Montefiori DC, Moore JP, Nixon DF, Overbaugh J, Pauza CD, Richman DD, Saag MS, Sattentau Q, Schooley RT, Shattock R, Shaw GM, Stevenson M, Trkola A, Wainberg MA, Weiss RA, Wolinsky S, Zack JA.

    Science. 2006 Nov 10;314(5801):924-5. Epub 2006 Oct 24. No abstract available. PMID: 17062652 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition.

    Chiu YL, Witkowska HE, Hall SC, Santiago M, Soros VB, Esnault C, Heidmann T, Greene WC.

    Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15588-93. Epub 2006 Oct 9.PMID: 17030807 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    NF-kappaB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity.

    O'Mahony A, Raber J, Montano M, Foehr E, Han V, Lu SM, Kwon H, LeFevour A, Chakraborty-Sett S, Greene WC.

    Mol Cell Biol. 2006 Oct;26(19):7283-98.PMID: 16980629 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.

    Zimmerman ES, Sherman MP, Blackett JL, Neidleman JA, Kreis C, Mundt P, Williams SA, Warmerdam M, Kahn J, Hecht FM, Grant RM, de Noronha CM, Weyrich AS, Greene WC, Planelles V.

    J Virol. 2006 Nov;80(21):10407-18. Epub 2006 Sep 6.PMID: 16956949 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    APOBEC3G and HIV-1:Strike and Counterstrike.

    Soros VB, Greene WC.

    Curr Infect Dis Rep. 2006 Jun;8(4):317-23.PMID: 16822376 [PubMed - in process]Related articles

    29.

    Multifaceted antiviral actions of APOBEC3 cytidine deaminases.

    Chiu YL, Greene WC.

    Trends Immunol. 2006 Jun;27(6):291-7. Epub 2006 May 4. Review.PMID: 16678488 [PubMed - indexed for MEDLINE]Related articles

    30.

    Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation.

    Kreisberg JF, Yonemoto W, Greene WC.

    J Exp Med. 2006 Apr 17;203(4):865-70. Epub 2006 Apr 10.PMID: 16606671 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin.

    Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, Greene WC, Valente AJ.

    J Biol Chem. 2006 Jun 2;281(22):15099-109. Epub 2006 Mar 22.PMID: 16554298 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Human immunodeficiency virus fusion to dendritic cells declines as cells mature.

    Cavrois M, Neidleman J, Kreisberg JF, Fenard D, Callebaut C, Greene WC.

    J Virol. 2006 Feb;80(4):1992-9.PMID: 16439555 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.

    Chiu YL, Greene WC.

    J Biol Chem. 2006 Mar 31;281(13):8309-12. Epub 2005 Dec 30. Review.PMID: 16407183 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.

    Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E, Greene WC.

    EMBO J. 2006 Jan 11;25(1):139-49. Epub 2005 Dec 1.PMID: 16319923 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement.

    Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams SA, Greene WC.

    J Immunol. 2005 Nov 1;175(9):6050-7.PMID: 16237100 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    NF-kappaB RelA phosphorylation regulates RelA acetylation.

    Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, Greene WC.

    Mol Cell Biol. 2005 Sep;25(18):7966-75.PMID: 16135789 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Assessing acetylation of NF-kappaB.

    Chen LF, Greene WC.

    Methods. 2005 Aug;36(4):368-75.PMID: 16111893 [PubMed - indexed for MEDLINE]Related articles

    38.

    Lethal cutaneous disease in transgenic mice conditionally expressing type I human T cell leukemia virus Tax.

    Kwon H, Ogle L, Benitez B, Bohuslav J, Montano M, Felsher DW, Greene WC.

    J Biol Chem. 2005 Oct 21;280(42):35713-22. Epub 2005 Aug 16.PMID: 16105841 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

    Chiu YL, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, Greene WC.

    Nature. 2005 May 5;435(7038):108-14. Epub 2005 Apr 13.PMID: 15829920 [PubMed - indexed for MEDLINE]Related articles

    40.

    Host factors regulating post-integration latency of HIV.

    Williams SA, Greene WC.

    Trends Microbiol. 2005 Apr;13(4):137-9.PMID: 15817380 [PubMed - indexed for MEDLINE]Related articles

    41.

    Protecting APOBEC3G: a potential new target for HIV drug discovery.

    Stopak K, Greene WC.

    Curr Opin Investig Drugs. 2005 Feb;6(2):141-7. Review.PMID: 15751736 [PubMed - indexed for MEDLINE]Related articles

    42.

    Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef.

    Keppler OT, Allespach I, Schüller L, Fenard D, Greene WC, Fackler OT.

    J Virol. 2005 Feb;79(3):1655-65.PMID: 15650191 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.

    Cavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC.

    Virology. 2004 Oct 10;328(1):36-44.PMID: 15380356 [PubMed - indexed for MEDLINE]Related articles

    45.

    The brightening future of HIV therapeutics.

    Greene WC.

    Nat Immunol. 2004 Sep;5(9):867-71. Review. No abstract available. PMID: 15334078 [PubMed - indexed for MEDLINE]Related articles

    46.

    Redistricting the retroviral restriction factors.

    Greene WC.

    Nat Med. 2004 Aug;10(8):778-80. No abstract available. PMID: 15286773 [PubMed - indexed for MEDLINE]Related articles

    47.

    Prostratin antagonizes HIV latency by activating NF-kappaB.

    Williams SA, Chen LF, Kwon H, Fenard D, Bisgrove D, Verdin E, Greene WC.

    J Biol Chem. 2004 Oct 1;279(40):42008-17. Epub 2004 Jul 28.PMID: 15284245 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Regulation of NF-kappaB action by reversible acetylation.

    Greene WC, Chen LF.

    Novartis Found Symp. 2004;259:208-17; discussion 218-25. Review.PMID: 15171256 [PubMed - indexed for MEDLINE]Related articles

    49.

    Shaping the nuclear action of NF-kappaB.

    Chen LF, Greene WC.

    Nat Rev Mol Cell Biol. 2004 May;5(5):392-401. Review. No abstract available. PMID: 15122352 [PubMed - indexed for MEDLINE]Related articles

    50.

    p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.

    Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC.

    J Biol Chem. 2004 Jun 18;279(25):26115-25. Epub 2004 Apr 8.PMID: 15073170 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...